Xia Chenhui, Zhang Jiale, Chen Huixi, Jiang Weimin, Zhou Shaofeng, Zheng Huijuan, Sun Weiwei
Department of Nephrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, No.5 Hai Yun Cang, Dongcheng District, Beijing 100700, China; Renal Research Institute of Beijing University of Chinese Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, No.5 Hai Yun Cang, Dongcheng District, Beijing 100700, China; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, No.5 Hai Yun Cang, Dongcheng District, 100700, Beijing, China.
Department of Nephrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, No.5 Hai Yun Cang, Dongcheng District, Beijing 100700, China; Renal Research Institute of Beijing University of Chinese Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, No.5 Hai Yun Cang, Dongcheng District, Beijing 100700, China; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, No.5 Hai Yun Cang, Dongcheng District, 100700, Beijing, China.
Int Immunopharmacol. 2025 Jun 23;162:115121. doi: 10.1016/j.intimp.2025.115121.
Mitochondrial homeostasis imbalance plays an important role in the development of diabetic kidney disease (DKD). Kaempferol is a key bioactive compound widely present in the rhizomes of Kaempferia L. and vegetables. Its anti-inflammatory and antioxidant properties have gained increasing attention in treating various metabolic diseases. This study investigated whether kaempferol could improve mitochondrial structure and function by regulating mitochondrial dynamics and mitophagy in DKD. A DKD rat model was established via unilateral nephrectomy and streptozotocin injection. Renal function, histopathology, and inflammatory factors were assessed, along with fibrosis, apoptosis, mitochondrial dynamics, and mitophagy-related proteins. Meanwhile, an AGEs-induced HK-2 cell injury model was used to evaluate autophagic flux and mitochondrial function and morphology through ad-mCherry-GFP-LC3B transduction, JC-1 staining, and MitoTracker probes. In vivo results showed that kaempferol exhibited significant anti-inflammatory, anti-apoptotic, and anti-fibrotic effects in DKD rats. Moreover, kaempferol demonstrated good safety by alleviating hepatic fibrosis. It also restored mitochondrial dynamics by promoting the upregulation of mitochondrial fusion proteins (Mfn1, OPA1) and the downregulation of fission proteins (Drp1, Fis1). In addition, kaempferol enhanced mitochondrial biogenesis by upregulating PGC-1α and TFAM. Notably, kaempferol reactivated mitophagy, as evidenced by increased levels of PINK1, Parkin, LC3, Beclin1, and ATG5, along with a reduction in p62 levels. In vitro, kaempferol further demonstrated its antioxidative potential by increasing SOD levels and decreasing MDA levels. Additionally, it promoted autophagic induction and facilitated the fusion of autophagosomes with lysosomes. These combined effects led to the restoration of mitochondrial membrane potential and structural integrity, while reducing ROS production and enhancing ATP generation. In conclusion, kaempferol promotes mitochondrial fusion, restores mitophagy, enhances autophagy flux, and facilitates mitochondrial clearance, showing the potential to mitigate kidney injury and slow disease progression in DKD.
线粒体稳态失衡在糖尿病肾病(DKD)的发展中起重要作用。山奈酚是一种广泛存在于山柰根茎和蔬菜中的关键生物活性化合物。其抗炎和抗氧化特性在治疗各种代谢性疾病中越来越受到关注。本研究调查了山奈酚是否可以通过调节DKD中的线粒体动力学和线粒体自噬来改善线粒体结构和功能。通过单侧肾切除和链脲佐菌素注射建立DKD大鼠模型。评估肾功能、组织病理学和炎症因子,以及纤维化、细胞凋亡、线粒体动力学和线粒体自噬相关蛋白。同时,使用晚期糖基化终末产物(AGEs)诱导的HK-2细胞损伤模型,通过腺病毒-mCherry-GFP-LC3B转导、JC-1染色和MitoTracker探针评估自噬通量以及线粒体功能和形态。体内结果表明,山奈酚在DKD大鼠中表现出显著的抗炎、抗凋亡和抗纤维化作用。此外,山奈酚通过减轻肝纤维化显示出良好的安全性。它还通过促进线粒体融合蛋白(Mfn1、OPA1)的上调和裂变蛋白(Drp)1、Fis1)的下调来恢复线粒体动力学。此外,山奈酚通过上调PGC-1α和线粒体转录因子A(TFAM)来增强线粒体生物合成。值得注意的是,山奈酚重新激活了线粒体自噬,表现为PINK1、Parkin、LC3、Beclin1和自噬相关蛋白5(ATG5)水平升高,以及p62水平降低。在体外,山奈酚通过提高超氧化物歧化酶(SOD)水平和降低丙二醛(MDA)水平进一步证明了其抗氧化潜力。此外,它促进自噬诱导并促进自噬体与溶酶体的融合。这些综合作用导致线粒体膜电位和结构完整性的恢复,同时减少活性氧(ROS)的产生并增强三磷酸腺苷(ATP)的生成。总之,山奈酚促进线粒体融合,恢复线粒体自噬,增强自噬通量,并促进线粒体清除,显示出减轻DKD肾损伤和减缓疾病进展的潜力。